Subclinical atherosclerosis in rheumatoid arthritis is driven by MicroRNA polymorphisms and NETosis

类风湿性关节炎中的亚临床动脉粥样硬化是由microRNA多态性和NETosis驱动的。

阅读:3

Abstract

BACKGROUND: Rheumatoid arthritis (RA) is associated with increased cardiovascular disease (CVD) risk, not fully explained by traditional risk factors. Neutrophil extracellular traps (NETs) and regulatory microRNA polymorphisms (miR-SNPs) may contribute to RA-related atherosclerosis through thromboinflammatory mechanisms. OBJECTIVES: To investigate whether miR-SNPs (rs2431697, rs3746444, rs11614913) are associated with subclinical atherosclerosis in RA, and whether NETosis mediates this relationship. METHODS: We genotyped 620 RA patients and 359 healthy controls. Carotid intima-media thickness (CIMT) was assessed in 65 RA patients and 75 controls. Circulating NETosis markers (cfDNA and citH3–DNA) were quantified. Logistic regression models evaluated the association between miR-SNPs and pathological CIMT (pCIMT), accounting for RA status and cardiovascular risk factors. RESULTS: The rs11614913 C allele was associated with RA susceptibility. pCIMT was significantly more frequent in RA patients than in controls (75.4% vs. 45.3%, p < 0.001). RA-specific associations were observed between pCIMT and both rs2431697 and rs3746444. The rs2431697 T allele was also associated with increased citH3–DNA levels, suggesting enhanced NETosis. CONCLUSIONS: miR-SNPs rs2431697 and rs3746444 are associated with subclinical atherosclerosis in RA and, in the case of rs2431697, preliminary results suggest that NETosis could be an underlying mechanism. These findings support their potential as biomarkers and therapeutic targets to reduce CVD risk in RA. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-025-03727-0.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。